Clinical Trial Update: Propylene Glycol-Free Melphalan Hydrochloride (Evomela) in AL Amyloidosis Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating propylene glycol-free melphalan hydrochloride (Evomela) in systemic amyloidosis (AL type) has been terminated with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Systemic Amyloidosis

Drugs mentioned

• Propylene glycol-free melphalan hydrochloride (melphalan hydrochloride)

Snippet

Sponsor: Boston Medical Center | Conditions: Amyloidosis; Systemic | Phase 2 | Status: TERMINATED | Results posted: 2023-05-24